Cinazin Plus 20/40 mg Tablet

Cinazin Plus 20/40 mg Tablet

DESCRIPTION

Cinazin Plus is a combination product of Cinnarizine & Dimenhydrinate. Dimenhydrinate acts predominantly on the central vestibular system. It acts as antihistamine with anticholinergic (antimuscarinic) properties, exerting parasympatholytic and centrally depressant effects. The substance exhibits anti-emetic and antivertiginous effects through influencing the chemoreceptor trigger zone in the region of the 4th ventricle. Cinnarizine acts predominantly on the peripheral vestibular system. Cinnarizine due to its calcium antagonistic properties acts mainly as a vestibular sedative through inhibition of the calcium influx into the vestibular sensory cells. Both Cinnarizine and Dimenhydrinate are known to be effective in the treatment of vertigo. The combination product is more effective than the individual compounds.

COMPOSITION

Each film-coated tablet contains Cinnarizine BP 20 mg and Dimenhydrinate USP 40 mg.

INDICATIONS

Use in the treatment of vertigo symptoms of various origins.

DOSAGE & ADMINISTRATION

Adults: One tablet three times a day, to be taken (not chewed) with some liquid after meals.

Children and adolescents under the age of 18 years: Cinazin Plus (Cinnarizine & Dimenhydrinate) is not recommended in children and adolescents under the age of 18 years because there are no data available on the use of the drug in this age group. Elderly: Dosage as for adults. In general, the duration of treatment should not exceed four weeks.

OR AS DIRECTED BY PHYSICIAN

SIDE EFFECTS

Side effects include drowsiness, dizziness, blurred vision, allergic skin reactions, fatigue and gastrointestinal upset.

CONTRAINDICATIONS

Cinazin Plus (Cinnarizine & Dimenhydrinate) should not be used by patients with severe hepatic impairment. It is contra-indicated in patients with known hypersensitivity to the active substances, diphenhydramine or other antihistamines of similar structure. Cinazin Plus (Cinnarizine & Dimenhydrinate) should not be used in patients with angle-closure glaucoma, convulsions, suspicion of raised intracranial pressure, alcohol abuse or urine retention due to urethroprostatic disorders.

PRECAUTIONS

Caution should be exercised when administering Cinazin Plus (Cinnarizine & Dimenhydrinate) to patients with Parkinson’s disease. The drug should be taken after meals to minimize any gastric irritation. It should be used with caution in patients with hypotension, hypertension, hyperthyroidism or severe coronary heart disease.

USE IN PREGNANCY & LACTATION

The safety of Cinazin Plus (Cinnarizine & Dimenhydrinate) in human pregnancy has not been established. As Cinnarizine and Dimenhydrinate are excreted in human breast milk, It should not be taken by women who are breast feeding.

DRUG INTERACTIONS

Procarbazine may enhance the effect of Cinazin Plus (Cinnarizine & Dimenhydrinate). In common with other antihistamines, Cinnarizine & Dimenhydrinate may potentiate the sedative effects of CNS depressants including alcohol, barbiturates, narcotic analgesics and tranquillizers. Cinazin Plus (Cinnarizine & Dimenhydrinate) may also enhance the effects of antihypertensives, ephedrine and anticholinergics such as atropine and tricyclic antidepressants.

SUPPLY

Each box contains 5 x 10 tablets in Alu-PVDC blister strips